# A Study of Real-world Cohort of Pulmonary Arterial Hypertension (PAH) Participants

> **NCT04955990** · PHASE4 · TERMINATED · sponsor: **Actelion** · enrollment: 232 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **OTHER:** PAH Therapies

## Key facts

- **NCT ID:** NCT04955990
- **Lead sponsor:** Actelion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-10-14
- **Primary completion:** 2022-12-20
- **Final completion:** 2022-12-20
- **Target enrollment:** 232 (ACTUAL)
- **Why stopped:** The sponsor decided to terminate the study.
- **Last updated:** 2025-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04955990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04955990, "A Study of Real-world Cohort of Pulmonary Arterial Hypertension (PAH) Participants". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04955990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*